Works matching AU Lin, Chih-Lang


Results: 54
    1
    2
    3
    4

    Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03006-3
    By:
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Chang, Te-Sheng;
    • Lo, Ching-Chu;
    • Hung, Chao-Hung;
    • Huang, Chien-Wei;
    • Chong, Lee-Won;
    • Cheng, Pin-Nan;
    • Yeh, Ming-Lun;
    • Peng, Cheng-Yuan;
    • Cheng, Chien-Yu;
    • Huang, Jee-Fu;
    • Bair, Ming-Jong;
    • Lin, Chih-Lang;
    • Yang, Chi-Chieh;
    • Wang, Szu-Jen;
    • Hsieh, Tsai-Yuan;
    • Lee, Tzong-Hsi;
    • Lee, Pei-Lun;
    • Wu, Wen-Chih
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Carbon dioxide insufflation during colonoscopy can significantly decrease post-interventional abdominal discomfort in deeply sedated patients: A prospective, randomized, double-blinded, controlled trial.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 4, p. 808, doi. 10.1111/jgh.13181
    By:
    • Chen, Shuo ‐ Wei;
    • Hui, Chung ‐ Kun;
    • Chang, Jia ‐ Jang;
    • Lee, Tsung ‐ Shih;
    • Chan, Siu ‐ Cheung;
    • Chien, Cheng ‐ Hung;
    • Hu, Ching ‐ Chih;
    • Lin, Chih ‐ Lang;
    • Chen, Li ‐ Wei;
    • Liu, Ching ‐ Jung;
    • Yen, Cho ‐ Li;
    • Hsieh, Po ‐ Jen;
    • Liu, Cheng ‐ Kun;
    • Su, Chih ‐ Sheng;
    • Yu, Chia ‐ Ying;
    • Chien, Rong ‐ Nan
    Publication type:
    Article
    12

    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.

    Published in:
    Digestive Diseases & Sciences, 2024, v. 69, n. 9, p. 3501, doi. 10.1007/s10620-024-08512-8
    By:
    • Chang, Chin-Wei;
    • Hsu, Wei-Fan;
    • Tseng, Kuo-Chih;
    • Chen, Chi-Yi;
    • Cheng, Pin-Nan;
    • Hung, Chao-Hung;
    • Lo, Ching-Chu;
    • Bair, Ming-Jong;
    • Chen, Chien-Hung;
    • Lee, Pei-Lun;
    • Lin, Chun-Yen;
    • Kuo, Hsing-Tao;
    • Chen, Chun-Ting;
    • Yang, Chi-Chieh;
    • Huang, Jee-Fu;
    • Tai, Chi-Ming;
    • Hu, Jui-Ting;
    • Lin, Chih-Lang;
    • Su, Wei-Wen;
    • Tsai, Wei-Lun
    Publication type:
    Article
    13
    14

    Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan.

    Published in:
    Liver International, 2021, v. 41, n. 6, p. 1265, doi. 10.1111/liv.14849
    By:
    • Chen, Chi‐Yi;
    • Huang, Chung‐Feng;
    • Cheng, Pin‐Nan;
    • Tseng, Kuo‐Chih;
    • Lo, Ching‐Chu;
    • Kuo, Hsing‐Tao;
    • Huang, Yi‐Hsiang;
    • Tai, Chi‐Ming;
    • Peng, Cheng‐Yuan;
    • Bair, Ming‐Jong;
    • Chen, Chien‐Hung;
    • Yeh, Ming‐Lun;
    • Lin, Chih‐Lang;
    • Lin, Chun‐Yen;
    • Lee, Pei‐Lun;
    • Chong, Lee‐Won;
    • Hung, Chao‐Hung;
    • Huang, Jee‐Fu;
    • Yang, Chi‐Chieh;
    • Hu, Jui‐Ting
    Publication type:
    Article
    15
    16
    17

    Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.

    Published in:
    Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1199, doi. 10.1007/s40121-024-00968-5
    By:
    • Yang, Chun-Chi;
    • Huang, Chung-Feng;
    • Chang, Te-Sheng;
    • Lo, Ching-Chu;
    • Hung, Chao-Hung;
    • Huang, Chien-Wei;
    • Chong, Lee-Won;
    • Cheng, Pin-Nan;
    • Yeh, Ming-Lun;
    • Peng, Cheng-Yuan;
    • Cheng, Chien-Yu;
    • Huang, Jee-Fu;
    • Bair, Ming-Jong;
    • Lin, Chih-Lang;
    • Yang, Chi-Chieh;
    • Wang, Szu-Jen;
    • Hsieh, Tsai-Yuan;
    • Lee, Tzong-Hsi;
    • Lee, Pei-Lun;
    • Wu, Wen-Chih
    Publication type:
    Article
    18

    Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan.

    Published in:
    Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 485, doi. 10.1007/s40121-021-00576-7
    By:
    • Cheng, Pin-Nan;
    • Mo, Lein-Ray;
    • Chen, Chun-Ting;
    • Chen, Chi-Yi;
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Lo, Ching-Chu;
    • Tseng, Kuo-Chih;
    • Huang, Yi-Hsiang;
    • Tai, Chi-Ming;
    • Peng, Cheng-Yuan;
    • Bair, Ming-Jong;
    • Chen, Chien-Hung;
    • Yeh, Ming-Lun;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Lee, Pei-Lun;
    • Chong, Lee-Won;
    • Hung, Chao-Hung;
    • Chang, Te Sheng
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Real‐world efficacy and safety of universal 8‐week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre‐end‐stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

    Published in:
    Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 2, p. 1, doi. 10.1002/kjm2.12929
    By:
    • Wang, Szu‐Jen;
    • Huang, Chung‐Feng;
    • Chang, Te‐Sheng;
    • Lo, Ching‐Chu;
    • Hung, Chao‐Hung;
    • Huang, Chien‐Wei;
    • Chong, Lee‐Won;
    • Cheng, Pin‐Nan;
    • Yeh, Ming‐Lun;
    • Peng, Cheng‐Yuan;
    • Cheng, Chien‐Yu;
    • Huang, Jee‐Fu;
    • Bair, Ming‐Jong;
    • Lin, Chih‐Lang;
    • Yang, Chi‐Chieh;
    • Kuo, Hsing‐Tao;
    • Hsieh, Tsai‐Yuan;
    • Lee, Tzong‐Hsi;
    • Lee, Pei‐Lun;
    • Wu, Wen‐Chih
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.

    Published in:
    Viruses (1999-4915), 2022, v. 14, n. 2, p. 333, doi. 10.3390/v14020333
    By:
    • Chen, Yen-Chun;
    • Chang, Te-Sheng;
    • Chen, Chien-Hung;
    • Cheng, Pin-Nan;
    • Lo, Ching-Chu;
    • Mo, Lein-Ray;
    • Chen, Chun-Ting;
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Huang, Yi-Hsiang;
    • Tai, Chi-Ming;
    • Peng, Cheng-Yuan;
    • Bair, Ming-Jong;
    • Yeh, Ming-Lun;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Lee, Pei-Lun;
    • Chong, Lee-Won;
    • Hung, Chao-Hung;
    • Huang, Jee-Fu
    Publication type:
    Article
    41
    42

    Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease.

    Published in:
    NPJ Digital Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s41746-022-00713-7
    By:
    • Wu, I-Wen;
    • Tsai, Tsung-Hsien;
    • Lo, Chi-Jen;
    • Chou, Yi-Ju;
    • Yeh, Chi-Hsiao;
    • Chan, Yun-Hsuan;
    • Chen, Jun-Hong;
    • Hsu, Paul Wei-Che;
    • Pan, Heng-Chih;
    • Hsu, Heng-Jung;
    • Chen, Chun-Yu;
    • Lee, Chin-Chan;
    • Shyu, Yu-Chiau;
    • Lin, Chih-Lang;
    • Cheng, Mei-Ling;
    • Lai, Chi-Chun;
    • Sytwu, Huey-Kang;
    • Tsai, Ting-Fen
    Publication type:
    Article
    43
    44

    Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis.

    Published in:
    Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-43554-3
    By:
    • Chen, Chun-Hsien;
    • Chen, Chien-Hung;
    • Lin, Chih-Lang;
    • Lin, Chun-Yen;
    • Hu, Tsung-Hui;
    • Tung, Shui-Yi;
    • Hsieh, Sen-Yung;
    • Lu, Sheng-Nan;
    • Chien, Rong-Nan;
    • Hung, Chao-Hung;
    • Sheen, I-Shyan
    Publication type:
    Article
    45
    46
    47
    48
    49
    50